Cargando…

Profile of brivaracetam and its potential in the treatment of epilepsy

Brivaracetam (BRV) (UCB 34714) is currently under review by the US Food and Drug Administration and European Medicines Agency for approval as an add-on treatment for adult patients with partial seizures. Similar to levetiracetam (LEV), BRV acts as a high-affinity ligand of the synaptic vesicle prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferlazzo, Edoardo, Russo, Emilio, Mumoli, Laura, Sueri, Chiara, Gasparini, Sara, Palleria, Caterina, Labate, Angelo, Gambardella, Antonio, De Sarro, Giovambattista, Aguglia, Umberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/ https://www.ncbi.nlm.nih.gov/pubmed/26664121 http://dx.doi.org/10.2147/NDT.S60849

Ejemplares similares

Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures
por: Mumoli, Laura, et al.
Publicado: (2015)

The Natural History of Epilepsy in 163 Untreated Patients: Looking for “Oligoepilepsy”
por: Gasparini, Sara, et al.
Publicado: (2016)

Positivity to p-ANCA in patients with status epilepticus
por: Ferlazzo, Edoardo, et al.
Publicado: (2014)

A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide
por: Mumoli, Laura, et al.
Publicado: (2013)

Rosacea-like facial rash related to metformin administration in a young woman
por: Mumoli, Laura, et al.
Publicado: (2014)

Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
por: Siniscalchi, Antonio, et al.
Publicado: (2012)

Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience
por: Mammì, Anna, et al.
Publicado: (2022)

Voxel-based morphometry of adulthood patients with temporal lobe epilepsy
por: Labate, A, et al.
Publicado: (2010)

Information Theoretic-Based Interpretation of a Deep Neural Network Approach in Diagnosing Psychogenic Non-Epileptic Seizures
por: Gasparini, Sara, et al.
Publicado: (2018)

Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2021)

Vertigo/dizziness as a Drugs’ adverse reaction
por: Chimirri, Serafina, et al.
Publicado: (2013)

Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study
por: Barbieri, Maria Antonietta, et al.
Publicado: (2020)

Brivaracetam in treating epileptic encephalopathy and refractory focal epilepsies in patients under 14 years of age
por: RUSSO, Angelo, et al.
Publicado: (2021)

Brivaracetam in the Treatment of Patients with Epilepsy—First Clinical Experiences
por: Zahnert, Felix, et al.
Publicado: (2018)

Convolutional Neural Network Classification of Rest EEG Signals among People with Epilepsy, Psychogenic Non Epileptic Seizures and Control Subjects
por: Lo Giudice, Michele, et al.
Publicado: (2022)

Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2018)

Corrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2020)

Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
por: Lattanzi, Simona, et al.
Publicado: (2022)

Serological Response to SARS-CoV-2 Messenger RNA Vaccine: Real-World Evidence from Italian Adult Population
por: Papadopoli, Rosa, et al.
Publicado: (2021)

Emerging drugs for partial-onset epilepsy: a review of brivaracetam
por: Gao, Lan, et al.
Publicado: (2016)

New developments in the management of partial-onset epilepsy: role of brivaracetam
por: Coppola, Giangennaro, et al.
Publicado: (2017)

Brivaracetam in the treatment of epilepsy: a review of clinical trial data
por: Feyissa, Anteneh M
Publicado: (2019)

A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies
por: Musumeci, Olimpia, et al.
Publicado: (2020)

Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study)
por: Coppola, Antonietta, et al.
Publicado: (2020)

Real-life burden of adverse reactions to biological therapy in inflammatory bowel disease: a single-centre prospective case series
por: Larussa, Tiziana, et al.
Publicado: (2021)

Safety and efficacy of generic drugs with respect to brand formulation
por: Gallelli, Luca, et al.
Publicado: (2013)

Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy
por: Leporini, Christian, et al.
Publicado: (2022)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells
por: Rizzo, Ambra, et al.
Publicado: (2017)

Neuropsychiatric profile in average intelligent individuals with coexisting epilepsy and psychogenic non‐epileptic seizures
por: Giugno, Alessia, et al.
Publicado: (2023)

Pharmacokinetic drug-drug interaction and their implication in clinical management
por: Palleria, Caterina, et al.
Publicado: (2013)

Skin rash during treatment with generic itraconazole
por: De Vuono, Antonio, et al.
Publicado: (2014)

Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years
por: Schoemaker, Rik, et al.
Publicado: (2017)

Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice
por: Stefanatou, Maria, et al.
Publicado: (2021)

Clinical and Electroencephalography Assessment of the Effects of Brivaracetam in the Treatment of Drug-Resistant Focal Epilepsy
por: Savastano, Ersilia, et al.
Publicado: (2021)

Safety and efficacy of brivaracetam in children epilepsy: a systematic review and meta-analysis
por: Song, Ting, et al.
Publicado: (2023)

Validation Study of Italian Version of Inventory for Déjà Vu Experiences Assessment (I-IDEA): A Screening Tool to Detect Déjà Vu Phenomenon in Italian Healthy Individuals
por: Mumoli, Laura, et al.
Publicado: (2017)

Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open‐label trial
por: Farkas, Mark Kristof, et al.
Publicado: (2022)

Acute and long‐term effects of brivaracetam and brivaracetam–diazepam combinations in an experimental model of status epilepticus
por: Niquet, Jerome, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ur6ct8abbg0jiqi8bvmcgo1vms